Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease.
Uhl
G R
GR
Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA.
D002352:Carrier Proteins / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009410:Nerve Degeneration / Q000378:metabolism* / Q000473:pathology; D009419:Nerve Tissue Proteins / Q000502:physiology; D009474:Neurons / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology
D002352:Carrier Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D004298:Dopamine